Cargando…

Visual and refractive outcomes following implantation of a new trifocal intraocular lens

BACKGROUND: Independence from all optical aids, and freedom from unwanted symptoms, following cataract and lens surgery remains the ultimate goal of both patient and surgeon. The development of trifocal IOL technology provides an ever-increasing range of options. The purpose of our study is to under...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawless, Michael, Hodge, Chris, Reich, Joe, Levitz, Lewis, Bhatt, Uday K., McAlinden, Colm, Roberts, Kate, Roberts, Timothy V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381044/
https://www.ncbi.nlm.nih.gov/pubmed/28396877
http://dx.doi.org/10.1186/s40662-017-0076-8
_version_ 1782519858980716544
author Lawless, Michael
Hodge, Chris
Reich, Joe
Levitz, Lewis
Bhatt, Uday K.
McAlinden, Colm
Roberts, Kate
Roberts, Timothy V.
author_facet Lawless, Michael
Hodge, Chris
Reich, Joe
Levitz, Lewis
Bhatt, Uday K.
McAlinden, Colm
Roberts, Kate
Roberts, Timothy V.
author_sort Lawless, Michael
collection PubMed
description BACKGROUND: Independence from all optical aids, and freedom from unwanted symptoms, following cataract and lens surgery remains the ultimate goal of both patient and surgeon. The development of trifocal IOL technology provides an ever-increasing range of options. The purpose of our study is to understand the predictability, safety and efficacy of a new trifocal intraocular lens (IOL) following cataract or refractive lens exchange (RLE) surgery. METHODS: This was a retrospective consecutive case series of patients undergoing cataract extraction or RLE followed by implantation of the Alcon IQ Panoptix IOL. Pre and postoperative refractive and visual parameters were recorded and evaluated. As the cohort followed a normal distribution, standard parametric tests were used. Paired t-test was used to compare the difference between target and postoperative refractive errors. The incidence of intraoperative and postoperative complications was also reported. RESULTS: The IOL was implanted in 66 eyes of 33 patients. Mean postoperative spherical equivalent (SE) refraction was -0.08 ± 0.25 dioptres (D). This was not significantly different from the target refraction (p = 0.841). Sixty-five percent of patients were within ± 0.25 D of the target SE refraction with 100% within ± 0.50 D of intended correction. Mean postoperative uncorrected distance visual acuity (UDVA) was 0.01 ± 0.10 LogMAR. All patients achieved an unaided distance acuity of 20/40 or better postoperatively. Binocularly, 100% saw 0.20 LogMAR or better at near without correction and 88.9% achieved this level for uncorrected intermediate visual acuity. No intraoperative complications were noted. Five patients complained of moderate haloes in the early postoperative period. CONCLUSION: The AcrySof IQ Panoptix IOL provides functional uncorrected visual acuity at distance, intermediate and near positions. Our results remain equivalent with existing trifocal IOL outcomes and provide surgeons with a further IOL alternative for the patient motivated to obtain true spectacle independence. Surgeons should consider individual reading and working requirements when counselling patients preoperatively to optimise postoperative patient satisfaction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40662-017-0076-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5381044
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53810442017-04-10 Visual and refractive outcomes following implantation of a new trifocal intraocular lens Lawless, Michael Hodge, Chris Reich, Joe Levitz, Lewis Bhatt, Uday K. McAlinden, Colm Roberts, Kate Roberts, Timothy V. Eye Vis (Lond) Research BACKGROUND: Independence from all optical aids, and freedom from unwanted symptoms, following cataract and lens surgery remains the ultimate goal of both patient and surgeon. The development of trifocal IOL technology provides an ever-increasing range of options. The purpose of our study is to understand the predictability, safety and efficacy of a new trifocal intraocular lens (IOL) following cataract or refractive lens exchange (RLE) surgery. METHODS: This was a retrospective consecutive case series of patients undergoing cataract extraction or RLE followed by implantation of the Alcon IQ Panoptix IOL. Pre and postoperative refractive and visual parameters were recorded and evaluated. As the cohort followed a normal distribution, standard parametric tests were used. Paired t-test was used to compare the difference between target and postoperative refractive errors. The incidence of intraoperative and postoperative complications was also reported. RESULTS: The IOL was implanted in 66 eyes of 33 patients. Mean postoperative spherical equivalent (SE) refraction was -0.08 ± 0.25 dioptres (D). This was not significantly different from the target refraction (p = 0.841). Sixty-five percent of patients were within ± 0.25 D of the target SE refraction with 100% within ± 0.50 D of intended correction. Mean postoperative uncorrected distance visual acuity (UDVA) was 0.01 ± 0.10 LogMAR. All patients achieved an unaided distance acuity of 20/40 or better postoperatively. Binocularly, 100% saw 0.20 LogMAR or better at near without correction and 88.9% achieved this level for uncorrected intermediate visual acuity. No intraoperative complications were noted. Five patients complained of moderate haloes in the early postoperative period. CONCLUSION: The AcrySof IQ Panoptix IOL provides functional uncorrected visual acuity at distance, intermediate and near positions. Our results remain equivalent with existing trifocal IOL outcomes and provide surgeons with a further IOL alternative for the patient motivated to obtain true spectacle independence. Surgeons should consider individual reading and working requirements when counselling patients preoperatively to optimise postoperative patient satisfaction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40662-017-0076-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-04 /pmc/articles/PMC5381044/ /pubmed/28396877 http://dx.doi.org/10.1186/s40662-017-0076-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lawless, Michael
Hodge, Chris
Reich, Joe
Levitz, Lewis
Bhatt, Uday K.
McAlinden, Colm
Roberts, Kate
Roberts, Timothy V.
Visual and refractive outcomes following implantation of a new trifocal intraocular lens
title Visual and refractive outcomes following implantation of a new trifocal intraocular lens
title_full Visual and refractive outcomes following implantation of a new trifocal intraocular lens
title_fullStr Visual and refractive outcomes following implantation of a new trifocal intraocular lens
title_full_unstemmed Visual and refractive outcomes following implantation of a new trifocal intraocular lens
title_short Visual and refractive outcomes following implantation of a new trifocal intraocular lens
title_sort visual and refractive outcomes following implantation of a new trifocal intraocular lens
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381044/
https://www.ncbi.nlm.nih.gov/pubmed/28396877
http://dx.doi.org/10.1186/s40662-017-0076-8
work_keys_str_mv AT lawlessmichael visualandrefractiveoutcomesfollowingimplantationofanewtrifocalintraocularlens
AT hodgechris visualandrefractiveoutcomesfollowingimplantationofanewtrifocalintraocularlens
AT reichjoe visualandrefractiveoutcomesfollowingimplantationofanewtrifocalintraocularlens
AT levitzlewis visualandrefractiveoutcomesfollowingimplantationofanewtrifocalintraocularlens
AT bhattudayk visualandrefractiveoutcomesfollowingimplantationofanewtrifocalintraocularlens
AT mcalindencolm visualandrefractiveoutcomesfollowingimplantationofanewtrifocalintraocularlens
AT robertskate visualandrefractiveoutcomesfollowingimplantationofanewtrifocalintraocularlens
AT robertstimothyv visualandrefractiveoutcomesfollowingimplantationofanewtrifocalintraocularlens